Finance

Beta
Lists
IMAX:NYSE
Imax Corp
$41.08
-5.26%
(-2.28) 1D
$41.08
-0.00% (-0.00070)
After hours
Closed: Jun 26, 4:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IMAX...
Open
$43.14
High
$43.56
Low
$41.02
Mkt. cap
2.26B
Avg. vol.
1.06M
Volume
3.15M
P/E ratio
62.05
52-wk high
$45.52
52-wk low
$24.20
EPS
$0.66
Beta
0.37
Shares outstanding
54.86M
No. of employees
679
Open
$43.14
High
$43.56
Low
$41.02
Mkt. cap
2.26B
Avg. vol.
1.06M
Volume
3.15M
P/E ratio
62.05
52-wk high
$45.52
52-wk low
$24.20
EPS
$0.66
Beta
0.37
Shares outstanding
54.86M
No. of employees
679
News stories
From sources across the web
About Imax Corp
CEO-
Employees679
Founded1967
HeadquartersMississauga, Ontario, Canada
SectorEntertainment
Websiteimax.com
Analyst ratings
Based on 9 analysts giving stock ratings to IMAX in the past 3 months
Strong buy
Buy
8
Hold
1
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for IMAX in the last 3 months.
Highest
Current $41.08
$60.00 (+46.06%)
Average
$47.44 (+15.48%)
Lowest
$41.00 (-0.19%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Joyce
Seaport Global
Buy
Maintained
$50.00
+21.7%
06/24/2026
Unknown Analyst
Wedbush
Buy
Reiterated
$46.00
+12%
05/26/2026
Mike Hickey
Benchmark Co.
Buy
Maintained
$60.00
+46.1%
05/22/2026
Drew Crum
B. Riley Securities
Buy
Maintained
$46.00
+12%
05/18/2026
Stephen Laszczyk
Goldman Sachs
Hold
Reiterated
$41.00
-0.2%
05/05/2026
Patrick Sholl
Barrington
Buy
Reiterated
$46.00
+12%
05/01/2026
Steve Frankel
Rosenblatt Securities
Buy
Maintained
$47.00
+14.4%
05/01/2026
David Karnovsky
J.P. Morgan
Buy
Maintained
$47.00
+14.4%
05/01/2026
Eric Handler
Roth MKM
Buy
Maintained
$44.00
+7.1%
05/01/2026
Last report
Apr 30, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.17 / $0.15
+10.75%beat
Revenue / Est. (USD)
81.38M / 79.90M
+1.85%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
91.68M
106.65M
125.21M
81.38M
Cost of goods sold
38.08M
39.38M
52.44M
35.56M
Cost of revenue
38.08M
39.38M
52.44M
35.56M
Research and development expenses
1.54M
1.50M
1.45M
1.80M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
35.44M
34.20M
35.53M
32.56M
Operating expense
38.60M
38.21M
39.46M
35.93M
Total operating expenses
76.68M
77.59M
91.90M
71.49M
Operating income
15.00M
29.06M
33.31M
9.89M
Other non operating income
-
-
-
-
EBT including unusual items
13.43M
27.82M
6.60M
8.49M
EBT excluding unusual items
14.19M
27.79M
32.10M
8.46M
Income tax expense
1.20M
5.20M
4.08M
2.42M
Effective tax rate
8.92%
18.71%
61.77%
28.51%
Other operating expenses
-
-
-
-
Net income
11.26M
20.66M
637.00K
4.23M
Net profit margin
12.28%
19.37%
0.51%
5.19%
Earnings per share
0.26
0.47
0.58
0.17
Interest and investment income
1.11M
557.00K
589.00K
468.00K
Interest expense
-1.93M
-1.83M
-1.80M
-1.90M
Net interest expenses
-813.00K
-1.28M
-1.21M
-1.43M
Depreciation and amortization charges
-
-
-
-
EBITDA
26.27M
40.10M
42.44M
21.28M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of IMAX
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer